Skip to content

Member

Liesbet SOMMEN

EPP · Belgium

Group
EPP PPE
Country
Belgium
Roll-call participation
95.8 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
94.3 %ⓘ of 5 679 votes where the group had a line · EPP median 93.6 %
More facts (5)
National party
CD&V Christen-Democratisch & Vlaams
In office
Since 16 Jul 2024
Against clear line
235 of 5 410 votesⓘ
Committees
EMPL, ENVI (substitute), FEMM (substitute), SANT (substitute)
Member id
256889
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

95.8 %

5 679 of 5 928 roll calls while in office

EPP median: 89.9 % (+5.9 pts)

Chamber median: 90.2 %

With majority line ⓘ

94.3 %

5 354 of 5 679 votes where their group had a line

EPP median: 93.6 % (+0.7 pts)

Against clear line ⓘ

4.3 %

235 of 5 410 votes where their group had a clear line

171 opposite (for ↔ against), 55 abstained against the line, 9 voted for or against when the line was to abstain

Abstention ⓘ

1.7 %

99 of 5 679 votes cast

Participation 95.8 % — EPP median 89.9 %, 196 members.ⓘ
Data as a table
Participation among the 196 members of the EPP with enough votes.
FigureParticipation
Liesbet SOMMEN95.8 %
EPP median89.9 %
Lowest in the group17.0 %
Highest in the group99.6 %
Members196
With majority line 94.3 % — EPP median 93.6 %, 196 members.ⓘ
Data as a table
With majority line among the 196 members of the EPP with enough votes.
FigureWith majority line
Liesbet SOMMEN94.3 %
EPP median93.6 %
Lowest in the group70.2 %
Highest in the group99.5 %
Members196
  • Whole term, 5 928 roll-call votes. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
11 Mar 2026Recommendation on enhanced EU-Canada cooperation in the current geopolitical context, including the threats to Canada’s economic stability and sovereignty Adopted 482 for, 108 against, 42 abstainedPosition: For Majority line: For
11 Mar 2026Tackling barriers to the single market for defence Adopted 393 for, 169 against, 67 abstainedPosition: For Majority line: For
11 Mar 2026Flagship European defence projects of common interest Adopted 448 for, 122 against, 38 abstainedPosition: For Majority line: For
10 Mar 2026Harmonising certain aspects of insolvency law Passed 498 for, 90 against, 28 abstainedPosition: For Majority line: For
10 Mar 2026Establishing an EU talent pool Passed 414 for, 182 against, 21 abstainedPosition: For Majority line: For
10 Mar 2026Increased efficiency of the External Action Guarantee Passed 441 for, 105 against, 81 abstainedPosition: For Majority line: For
10 Mar 2026European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2023 and 2024 Adopted 493 for, 92 against, 44 abstainedPosition: For Majority line: For
10 Mar 2026Housing crisis in the European Union with the aim of proposing solutions for decent, sustainable and affordable housing Adopted 367 for, 166 against, 84 abstainedPosition: For Majority line: For
10 Mar 2026Public access to documents - report 2022 - 2024 Adopted 602 for, 9 against, 8 abstainedPosition: For Majority line: For
10 Mar 2026Copyright and generative artificial intelligence – opportunities and challenges Adopted 460 for, 71 against, 88 abstainedPosition: For Majority line: For
10 Mar 2026Fisheries management approaches for safeguarding sensitive species, tackling invasive species and benefiting local economies Adopted 528 for, 21 against, 62 abstainedPosition: For Majority line: For
10 Mar 2026The upcoming European Research Area (ERA) Act Adopted 399 for, 78 against, 69 abstainedPosition: No vote recorded Majority line: For
24 Feb 2026Four years of Russia’s war of aggression against Ukraine and European contributions to a just peace and sustained security for Ukraine Adopted 437 for, 82 against, 70 abstainedPosition: For Majority line: For
12 Feb 2026Cooperation among enforcement authorities regarding unfair trading practices in the agri-food supply chain Passed 555 for, 0 against, 26 abstainedPosition: For Majority line: For
12 Feb 2026Post-election situation in Uganda and threats against opposition leader Bobi Wine Adopted 514 for, 3 against, 56 abstainedPosition: For Majority line: For
12 Feb 2026Systemic oppression, inhumane conditions and arbitrary detentions by the regime in Iran Adopted 524 for, 3 against, 41 abstainedPosition: For Majority line: For
12 Feb 2026Targeted expulsions of foreign journalists and foreign Christians in Türkiye under national security pretexts Adopted 502 for, 2 against, 59 abstainedPosition: For Majority line: For
12 Feb 2026Developing a new EU anti-poverty strategy Adopted 385 for, 141 against, 53 abstainedPosition: For Majority line: For
12 Feb 2026Addressing subcontracting chains and the role of intermediaries in order to protect workers’ rights Adopted 332 for, 209 against, 33 abstainedPosition: For Majority line: For
12 Feb 2026Recommendation to the Council on EU priorities for the 70th session of the UN Commission on the Status of Women Adopted 340 for, 141 against, 68 abstainedPosition: For Majority line: For
12 Feb 2026Situation in Northeast Syria, the violence against civilians and the need to maintain a sustainable ceasefire Adopted 363 for, 71 against, 81 abstainedPosition: For Majority line: For
11 Feb 2026Regulation implementing enhanced cooperation on the establishment of the Ukraine Support Loan for 2026 and 2027 Passed 458 for, 140 against, 44 abstainedPosition: For Majority line: For
11 Feb 2026Amending Regulation (EU) 2024/792 establishing the Ukraine Facility Passed 473 for, 140 against, 32 abstainedPosition: For Majority line: For
11 Feb 2026Amending the multiannual financial framework for the years 2021 to 2027 Consent given 490 for, 130 against, 32 abstainedPosition: For Majority line: For
11 Feb 2026Mobilisation of the European Globalisation Adjustment Fund: application EGF/2025/006 BE/Audi – Belgium Passed 593 for, 55 against, 9 abstainedPosition: For Majority line: For
11 Feb 2026Genetically modified soybean DBN-09004-6 Objection passed 461 for, 169 against, 22 abstainedPosition: Against Majority line: Against
11 Feb 2026Genetically modified maize T25 (ACS-ZMØØ3-2) Objection passed 462 for, 169 against, 22 abstainedPosition: Against Majority line: Against
11 Feb 2026Genetically modified cotton T304-40 Objection passed 428 for, 156 against, 22 abstainedPosition: Against Majority line: Against
11 Feb 2026Genetically modified cotton GHB614 × LLCotton25 Objection passed 463 for, 164 against, 21 abstainedPosition: Against Majority line: Against
11 Feb 2026Interim report in view of the consent procedure on the Agreement establishing an association between the EU and the Principality of Andorra and the Republic of San Marino Interim report adopted 552 for, 24 against, 75 abstainedPosition: For Majority line: For
11 Feb 2026EU strategic defence and security partnerships Adopted 440 for, 119 against, 85 abstainedPosition: For Majority line: For
10 Feb 2026Establishment of a list of safe countries of origin at Union level Passed 408 for, 184 against, 60 abstainedPosition: For Majority line: For
10 Feb 2026Application of the ‘safe third country’ concept Passed 396 for, 226 against, 30 abstainedPosition: For Majority line: For
10 Feb 2026Amending regulations on agricultural products as regards market rules and sectoral support measures in the wine sector and for aromatised wine products Passed 625 for, 15 against, 11 abstainedPosition: For Majority line: For
10 Feb 2026Amending the Measuring Instruments Directive Passed 594 for, 25 against, 23 abstainedPosition: For Majority line: For
10 Feb 2026Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products Passed 483 for, 102 against, 67 abstainedPosition: For Majority line: For
10 Feb 2026Framework for achieving climate neutrality Passed 413 for, 226 against, 12 abstainedPosition: For Majority line: For
10 Feb 2026European Union designs (codification) Passed 613 for, 5 against, 29 abstainedPosition: For Majority line: For
10 Feb 2026European Central Bank – annual report 2025 Adopted 443 for, 71 against, 117 abstainedPosition: For Majority line: For
22 Jan 2026Motion of censure on the Commission Rejected 165 for, 390 against, 10 abstainedPosition: Against Majority line: Against
22 Jan 2026Conviction and imminent sentencing of Jimmy Lai in Hong Kong Adopted 503 for, 9 against, 100 abstainedPosition: For Majority line: For
22 Jan 2026Case of Joseph Figueira Martin in the Central African Republic Adopted 582 for, 0 against, 35 abstainedPosition: For Majority line: For
22 Jan 2026Drones and new systems of warfare – the EU’s need to adapt to be fit for today’s security challenges Adopted 483 for, 68 against, 76 abstainedPosition: For Majority line: For
22 Jan 2026Choice of performance indicators for audit and budgetary control in the context of financing measures to support the implementation of future European competitiveness Adopted 318 for, 247 against, 67 abstainedPosition: For Majority line: For
22 Jan 2026European technological sovereignty and digital infrastructure Adopted 471 for, 68 against, 71 abstainedPosition: For Majority line: For
22 Jan 2026Brutal repression against protesters in Iran Adopted 562 for, 9 against, 57 abstainedPosition: For Majority line: For
22 Jan 2026Attempted takeover of Lithuania’s public broadcaster and the threat to democracy in Lithuania Adopted 385 for, 165 against, 35 abstainedPosition: For Majority line: For
21 Jan 2026Air passenger rights Amendments 1 + 243 (voted as one) adopted 632 for, 15 against, 9 abstainedPosition: For Majority line: For
21 Jan 2026EU-Bosnia and Herzegovina Agreement on operational activities carried out by the European Border and Coast Guard Agency in Bosnia and Herzegovina Consent given 565 for, 83 against, 14 abstainedPosition: For Majority line: For
21 Jan 2026Enhanced cooperation on the establishment of a Loan for Ukraine Consent given 499 for, 135 against, 24 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 7 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 20242323
18 Jul 202411
16 Sept 202421
18 Sept 202422
19 Sept 20249280
7 Oct 202422
8 Oct 202411
9 Oct 20241818
10 Oct 202440
21 Oct 202422
22 Oct 20241010
23 Oct 2024129129
24 Oct 20241313
13 Nov 202422
14 Nov 20243636
25 Nov 202422
26 Nov 20241818
27 Nov 20241111
28 Nov 20245757
17 Dec 2024130
18 Dec 2024330
19 Dec 2024450
20 Jan 202522
21 Jan 202511
22 Jan 202522
23 Jan 20254541
10 Feb 202511
11 Feb 20253227
12 Feb 20251010
13 Feb 2025300
10 Mar 202522
11 Mar 202599
12 Mar 2025228227
13 Mar 20252424
31 Mar 202533
1 Apr 20253535
2 Apr 2025251249
3 Apr 20256262
5 May 202555
6 May 20251010
7 May 2025220219
8 May 2025103103
21 May 202520
22 May 20255352
16 Jun 202522
17 Jun 20254141
18 Jun 20259191
19 Jun 20258785
7 Jul 202511
8 Jul 20255555
9 Jul 2025134133
10 Jul 20253636
8 Sept 202511
9 Sept 2025101101
10 Sept 20253434
11 Sept 20256968
6 Oct 202522
7 Oct 202555
8 Oct 20255555
9 Oct 20256565
20 Oct 202533
21 Oct 20251313
22 Oct 2025186185
23 Oct 20255554
13 Nov 2025267266
24 Nov 202533
25 Nov 20257575
26 Nov 2025100100
27 Nov 2025125125
15 Dec 202543
16 Dec 20256666
17 Dec 20254343
18 Dec 20254241
20 Jan 20266767
21 Jan 2026112112
22 Jan 20265858
9 Feb 202622
10 Feb 20263838
11 Feb 20261313
12 Feb 2026141139
24 Feb 20264342
9 Mar 202611
10 Mar 2026197196
11 Mar 20266059
12 Mar 20263434
25 Mar 202633
26 Mar 20266969
27 Apr 202622
28 Apr 2026225225
29 Apr 2026296296
30 Apr 20266868
18 May 202644
19 May 202633
20 May 20269695
21 May 20269898
15 Jun 202622
16 Jun 20264040
17 Jun 2026127126
18 Jun 2026770
6 Jul 202622
7 Jul 20267272
8 Jul 2026144144
9 Jul 20266767
14 Sept 202611
15 Sept 2026155154
16 Sept 20268080
17 Sept 2026124123

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Wouter BEKE EPPBelgium98 % of 5 492 shared89 %
Manfred WEBER EPPGermany95 % of 4 556 shared89 %
Willemien KONING EPPNetherlands94 % of 1 836 shared89 %
Isabel WISELER-LIMA EPPLuxembourg94 % of 5 525 shared89 %
Rasa JUKNEVIČIENĖ EPPLithuania94 % of 4 716 shared89 %
Martine KEMP EPPLuxembourg94 % of 4 654 shared89 %
Pekka TOVERI EPPFinland94 % of 5 049 shared89 %
Sandra KALNIETE EPPLatvia94 % of 5 220 shared89 %
Mika AALTOLA EPPFinland94 % of 4 771 shared89 %
Siegfried MUREŞAN EPPRomania94 % of 5 548 shared89 %

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Urmas PAET RenewEstonia90 % of 5 148 shared82 %
Hilde VAUTMANS RenewBelgium90 % of 5 497 shared82 %
Dan BARNA RenewRomania90 % of 5 014 shared82 %
Olivier CHASTEL RenewBelgium89 % of 5 117 shared82 %
Sophie WILMÈS RenewBelgium89 % of 3 949 shared82 %
Anna-Maja HENRIKSSON RenewFinland89 % of 5 099 shared82 %
Elsi KATAINEN RenewFinland89 % of 5 562 shared82 %
Katri KULMUNI RenewFinland88 % of 4 454 shared82 %
Stine BOSSE RenewDenmark88 % of 5 589 shared82 %
Eugen TOMAC RenewRomania88 % of 4 151 shared82 %

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Employment and Social AffairsEMPL CommitteeMember19 Jul 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Women’s Rights and Gender EqualityFEMM CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Delegation for relations with BelarusD-BY DelegationMember19 Sept 2024now
Delegation for Northern cooperation and for relations with Switzerland and Norway and to the EU-Iceland Joint Parliamentary Committee and the European Economic Area (EEA) Joint Parliamentary CommitteeDEEA DelegationMember19 Sept 2024now
Delegation to the Euronest Parliamentary AssemblyDEPA Parliamentary assemblyMember19 Sept 2024now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now
Intergroup on DemographyIG10-09 Intergroup / working groupMember3 Feb 2025now

Show all 19 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers following an application from Finland - EGF/2026/004 FI/Etelä-Suomi and Helsinki-Uusimaa paperShadow rapporteur for an opinionEMPL21 Sept 2026
Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers following an application from Spain – EGF/2026/002 ES/Galicia automotive ancillaryShadow rapporteur for an opinionEMPL7 Sept 2026
Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers following an application from Belgium – EGF/2026/001 BE/CoraShadow rapporteur for an opinionEMPL7 Sept 2026
Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers following an application from Finland – EGF/2026/003 FI/Valmet AutomotiveShadow rapporteur for an opinionEMPL7 Sept 2026
Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers following an application from Belgium – EGF/2025/009 BE/SoliverOpinion rapporteurEMPL19 May 2026
No dossier namedOfficial delegationEMPL19 Mar 2026
Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers following an application from Belgium – EGF/2025/008 BE/LibertyShadow rapporteur for an opinionEMPL9 Mar 2026
Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers following an application from Belgium - EGF/2025/004 BE/TupperwareShadow rapporteur for an opinionEMPL23 Feb 2026
Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers following an application from Austria - EGF/2025/005 AT/KTMShadow rapporteur for an opinionEMPL23 Feb 2026
Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers following an application from Belgium - EGF/2025/007 BE/CasaShadow rapporteur for an opinionEMPL23 Feb 2026

Show all 24 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

17 contributions recorded, 3 written statements; 6 on behalf of their group; 25 minutes of speaking time.

Show all 17 recent contributions

Questions and motions, 46

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
13 Jul 2026Support for the development of sexual assault centres in the EU E-10-2026-002872Written questionwith 20 co-authorsNot yet answered
3 Jul 2026Follow-up to the European Citizens’ Panel on Preparedness E-10-2026-002778Written questionwith 9 co-authors21 Aug 2026
10 Mar 2026German Bundeskartellamt inquiry into Amazon pricing practices E-10-2026-000989Written questionwith 24 co-authors5 May 2026
10 Feb 2026Urgent call for concrete short-term action to address the crisis in the European chemical sector P-10-2026-000556Priority written questionwith 2 co-authors19 Mar 2026
10 Feb 2026Need for a European limit on the number of children per sperm or egg donor E-10-2026-000557Written question9 Apr 2026
9 Feb 2026MOTION FOR A RESOLUTION on World Cancer Day B-10-2026-0141Motion for a resolutionwith 18 co-authors—
20 Jan 2026Commercialising last hope to cancer patients who have exhausted all other treatment options E-10-2026-000200Written question31 Mar 2026
18 Dec 2025Use of Eurokey by the elderly and people with disabilities E-10-2025-005021Written question23 Feb 2026
8 Dec 2025Ban on the sale of nitrous oxide to the general public O-10-2025-000046Oral questionwith 42 co-authorsNot yet answered
19 Nov 2025MOTION FOR A RESOLUTION on protection of EU consumers against the practices of certain e-commerce platforms: the case of child-like sex dolls, weapons and other illegal products and materials B-10-2025-0500Motion for a resolutionwith 71 co-authors—
3 Oct 2025Lack of standardisation of firefighting equipment as an obstacle to cross-border operations and European preparedness E-10-2025-003884Written questionwith 11 co-authors6 Jan 2026
30 Sept 2025Patchwork families: data collection and policy initiatives P-10-2025-003798Priority written question6 Nov 2025
30 Sept 2025Support for EU battery producers E-10-2025-003795Written questionwith 11 co-authors17 Apr 2026
9 Sept 2025Protection of journalists and investigation into killings in Gaza E-10-2025-003482Written questionwith 108 co-authors4 Nov 2025
17 Jul 2025Safeguarding minors against harmful content on video-sharing platform services through Union codes of conduct E-10-2025-002956Written question3 Sept 2025
17 Jul 2025The urgent need to revise the MDR and the IVDR: towards a workable framework for innovation and patient safety E-10-2025-002957Written question17 Oct 2025
17 Jul 2025Electronic invoicing for smaller non-profit associations E-10-2025-002955Written question19 Sept 2025
27 Jun 2025Positioning cardiomyopathy in the cardiovascular health plan E-10-2025-002613Written questionwith 6 co-authors22 Aug 2025
25 Jun 2025Implementation of emergency communication systems E-10-2025-002572Written questionwith 9 co-authors6 Aug 2025
17 Jun 2025The role of local authorities in addressing the financial and operational challenges posed by PFAS and other persistent chemical contaminants in Europe E-10-2025-002429Written questionwith 20 co-authors26 Aug 2025
11 Jun 2025Potential discrimination of traders on Amazon Marketplace E-10-2025-002348Written questionwith 1 co-author15 Jul 2025
11 Jun 2025Addressing menstrual poverty and introducing an EU menstrual health strategy E-10-2025-002340Written questionwith 30 co-authors27 Aug 2025
11 Jun 2025Impact of AI on creative sectors E-10-2025-002341Written questionwith 1 co-author24 Jul 2025
11 Jun 2025Preliminary investigative steps against Amazon – outcome of investigation E-10-2025-002339Written questionwith 1 co-author28 Jul 2025
2 Jun 2025Access for humanitarian aid to the Gaza Strip E-10-2025-002193Written questionwith 21 co-authors4 Aug 2025
28 May 2025Dangerous supplements promoted to young people via social media E-10-2025-002136Written question7 Aug 2025
28 May 2025Use of US digital platforms in EU projects E-10-2025-002131Written question30 Jul 2025
28 May 2025Safeguarding minors against harmful content on video-sharing platform services E-10-2025-002134Written question14 Aug 2025
28 May 2025Rise in THC and smart vapes on the European single market E-10-2025-002133Written question22 Aug 2025
9 Apr 2025Timeframe for the investigations into online platforms under the Digital Services Act E-10-2025-001454Written question3 Jun 2025
20 Mar 2025EU action to accelerate biotech solutions for autoimmune disease patients E-10-2025-001203Written questionwith 1 co-author23 Jun 2025
28 Feb 2025Action plan on rare diseases E-10-2025-000886Written questionwith 33 co-authors26 Jun 2025
26 Feb 2025Rare diseases P-10-2025-000845Priority written questionwith 7 co-authors2 May 2025
7 Feb 2025Harmonisation of cargo securing regulations E-10-2025-000565Written question22 Apr 2025
7 Feb 2025EU consumers misled by food labelling E-10-2025-000566Written question19 May 2025
7 Feb 2025Children’s series like CoComelon and PAW Patrol are harmful for children’s development E-10-2025-000563Written question16 Apr 2025
7 Feb 2025Negative impact of social media on vulnerable groups E-10-2025-000564Written question2 May 2025
28 Jan 2025State of play – revision of the roadworthiness package E-10-2025-000381Written question3 Apr 2025
28 Jan 2025Gender-based price discrimination (pink tax) E-10-2025-000379Written question2 May 2025
28 Jan 2025Green Deal – Translation into local action E-10-2025-000382Written question4 Apr 2025
28 Jan 2025Problems within e-commerce E-10-2025-000376Written question5 Jun 2025
28 Jan 2025Food safety – lead and cadmium in ceramics, glass and enamelled tableware and kitchenware E-10-2025-000380Written question29 Apr 2025
28 Jan 2025European scheme to prevent odometer manipulation E-10-2025-000378Written question10 Apr 2025
28 Jan 2025Labelling rules for textiles E-10-2025-000377Written question24 Apr 2025
17 Jan 2025MOTION FOR A RESOLUTION on the need for actions to address the continued oppression and fake elections in Belarus B-10-2025-0057Motion for a resolutionwith 29 co-authors—
26 Sept 2024The spread of bluetongue virus throughout the EU E-10-2024-001845Written questionwith 39 co-authors15 Nov 2024

Amendments tabled in committee, 53

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT35
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT21
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ537
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ534
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935 CJ539
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ536
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ534
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ532
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ534
19 Jun 2026Clean corporate vehicles CJ46-AM-789892 CJ462

Show all 53 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Belgium National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Liesbet SOMMEN”. Member record. memberId 256889. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/256889?docs=all&nb=all&page=5 (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/256889. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/256889?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-256889,
  author = {{EU Parl Watch Research}},
  title = {{Liesbet SOMMEN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/256889?docs=all&nb=all&page=5}},
  url = {https://news.eu-parl.st-solutions.dev/members/256889?docs=all&nb=all&page=5},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 256889. Official source: https://www.europarl.europa.eu/meps/en/256889. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}